ArticlePharmaceuticals (Basel, Switzerland)2020

Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells.

Anna Egorova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.